Human Anti-DLL4 (clone 21H3RK) scFv-Fc Chimera (CAT#: VS-0425-FY100)

This fusion protein targets DLL4 (Delta-like ligand 4), a protein involved in the Notch signaling pathway, which regulates cell differentiation and proliferation. By inhibiting DLL4, it can modulate angiogenesis and tumor growth, making it a potential therapeutic target in cancer.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Formats:
  • Isotype Switching:
  • Fc Engineering:
  • Modalities:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Host Species
  • Human
  • Type
  • Human IgG1, scFv-Fc
  • Specificity
  • Human DLL4
  • Species Reactivity
  • Human, Cynomolgus monkey
  • Clone
  • 21H3RK
  • Applications
  • Flow Cytometry
  • Related Disease
  • Cancer

Product Property

  • Purity
  • >95% as determined by SDS-PAGE
  • Concentration
  • Please refer to the vial label for the specific concentration.
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
  • Shipping
  • Ice packs

Applications

  • Application Notes
  • Flow Cytometry: 0.1 μg/mL
    The optimal dilution concentration is determined by the experiment.

Target

  • Alternative Names
  • Delta Like Canonical Notch Ligand 4; Drosophila Delta Homolog 4; Delta4; Delta-Like 4 Homolog (Drosophila); Delta-Like 4 (Drosophila); Delta-Like 4 Homolog; Delta-Like 4 Protein; Delta-Like Protein 4
  • Long Name
  • Delta Like Canonical Notch Ligand 4
  • Cellular Localization
  • Cell membrane
  • Post Translation Modifications
  • Glycosylation at Asn108, Asn183, Asn205, and Asn393
    Modification sites at PhosphoSitePlus
    Glycosylation from GlyGen 4 sites, 1 N-linked glycan (1 site)
  • Function
  • Involved in the Notch signaling pathway as Notch ligand.
    Activates NOTCH1 and NOTCH4.
    Involved in angiogenesis; negatively regulates endothelial cell proliferation and migration and angiogenic sprouting.
    Essential for retinal progenitor proliferation.
    Required for suppressing rod fates in late retinal progenitors as well as for proper generation of other retinal cell types.
    During spinal cord neurogenesis, inhibits V2a interneuron fate.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 21H3RK"

See other products for "DLL4"

Select a product category from the dropdown menu below to view related products.
Please select product type
Humanized Antibody Products Human Antibody Products Rat Antibody Products Chimeric Antibody Products Mouse Antibody Products IgG Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products ScFv Antibody Products Fab Antibody Products ADCC Enhanced Antibody Products Single Domain Antibody Products Antibody Magnetic Beads
CAT Product Name Application Type
TAB-204 Anti-Human DLL4 Recombinant Antibody (TAB-204) ELISA, FC, IP, FuncS, IF, Neut, WB IgG2 - kappa

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for VS-0425-FY100. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare